Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Disputes Do Not Pay Off, Merck Says: Sweet Spot In “Bitter Medicine”

Executive Summary

Aggressive patent defensive strategies do not pay off on Wall Street, Merck CEO Ray Gilmartin told Peter Jennings during an ABC News special, "Bitter Medicine: Pills, Profit and the Public Health," which aired May 29

You may also be interested in...



PhRMA Plans PR “Offense” In 2003 To Support Effort To Remove Access Issue

PhRMA's reconstituted public affairs program will devote half of its time and staff in 2003 to telling positive stories about the industry

PhRMA Plans PR “Offense” In 2003 To Support Effort To Remove Access Issue

PhRMA's reconstituted public affairs program will devote half of its time and staff in 2003 to telling positive stories about the industry

PhRMA’s Badge Of Merritt: AAHP Exec Joining Rx Association As Head Of PR

American Association of Health Plans Senior VP Mark Merritt is joining the Pharmaceutical Research & Manufacturers of America to head the trade association's public relations effort effective Oct. 7

Related Content

UsernamePublicRestriction

Register

PS039941

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel